Published online March 12, 2007
doi:10.1083/jcb.200611044
The Journal of Cell Biology, Vol. 176, No. 6, 787-793
The Rockefeller University Press, 0021-9525 $30.00
© 2007 Yang et al.
Absence of integrin-mediated TGFß1 activation in vivo recapitulates the phenotype of TGFß1-null mice
Zhiwei Yang,
Zhenyu Mu,
Branka Dabovic,
Vladimir Jurukovski,
Dawen Yu,
Joanne Sung,
Xiaozhong Xiong, and
John S. Munger
Department of Cell Biology, New York University School of Medicine, New York, NY 10016
Correspondence to John S. Munger: john.munger{at}med.nyu.edu
The multifunctional cytokine transforming growth factor (TGF) ß1 is secreted in a latent complex with its processed propeptide (latency-associated peptide [LAP]). TGFß1 must be functionally released from this complex before it can engage TGFß receptors. One mechanism of latent TGFß1 activation involves interaction of the integrins
vß6 and
vß8 with an RGD sequence in LAP; other putative latent TGFß1 activators include thrombospondin-1, oxidants, and various proteases. To assess the contribution of RGD-binding integrins to TGFß1 activation in vivo, we created a mutation in Tgfb1 encoding a nonfunctional variant of the RGD sequence (RGE). Mice with this mutation (Tgfb1RGE/RGE) display the major features of Tgfb1/ mice (vasculogenesis defects, multiorgan inflammation, and lack of Langerhans cells) despite production of normal levels of latent TGFß1. These findings indicate that RGD-binding integrins are requisite latent TGFß1 activators during development and in the immune system.
Abbreviations used in this paper: E, embryonic day; ES, embryonic stem; LAP, latency-associated peptide; LC, Langerhans cell; LTBP, latent TGFß-binding protein; MMP, matrix metalloproteinase; TSP1, thrombospondin-1.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Pechkovsky, D. V., Scaffidi, A. K., Hackett, T. L., Ballard, J., Shaheen, F., Thompson, P. J., Thannickal, V. J., Knight, D. A.
(2008). Transforming Growth Factor {beta}1 Induces {alpha}v{beta}3 Integrin Expression in Human Lung Fibroblasts via a {beta}3 Integrin-, c-Src-, and p38 MAPK-dependent Pathway. J. Biol. Chem.
283: 12898-12908
[Abstract]
[Full Text]
-
Ghannad, F., Nica, D., Garcia Fulle, M. I., Grenier, D., Putnins, E. E., Johnston, S., Eslami, A., Koivisto, L., Jiang, G., McKee, M. D., Hakkinen, L., Larjava, H.
(2008). Absence of {alpha}v{beta}6 Integrin Is Linked to Initiation and Progression of Periodontal Disease. Am. J. Pathol.
172: 1271-1286
[Abstract]
[Full Text]
-
Kisseleva, T., Brenner, D. A.
(2008). Mechanisms of Fibrogenesis. Exp. Biol. Med.
233: 109-122
[Abstract]
[Full Text]
-
Puthawala, K., Hadjiangelis, N., Jacoby, S. C., Bayongan, E., Zhao, Z., Yang, Z., Devitt, M. L., Horan, G. S., Weinreb, P. H., Lukashev, M. E., Violette, S. M., Grant, K. S., Colarossi, C., Formenti, S. C., Munger, J. S.
(2008). Inhibition of Integrin {alpha}v 6, an Activator of Latent Transforming Growth Factor- , Prevents Radiation-induced Lung Fibrosis. Am. J. Respir. Crit. Care Med.
177: 82-90
[Abstract]
[Full Text]
-
Wipff, P.-J., Rifkin, D. B., Meister, J.-J., Hinz, B.
(2007). Myofibroblast contraction activates latent TGF- 1 from the extracellular matrix. J. Cell Biol.
179: 1311-1323
[Abstract]
[Full Text]